Association Between Cerebral Blood Flow Change and Cognitive Function in Hemodialysis Patients
A Prospective Observational Study of the Association Between Cerebral Blood Flow Change and Cognitive Function in Older Maintenance Hemodialysis Patients
1 other identifier
observational
121
1 country
1
Brief Summary
The prevalence of cognitive impairment in maintenance hemodialysis (MHD) patients is 3 to 5 times higher than that in ordinary people, so it is essential to find the associated risk factors in this population. This project intends to evaluate whether changes in cerebral blood flow during dialysis have an impact on cognitive function in middle-aged and elderly MHD patients and clarify their influence on brain imaging characteristics. MHD patients who started hemodialysis at 3 to 6 months were selected to examine the difference in middle cerebral artery flow rate before and after dialysis by transcranial Doppler ultrasound to reflect the changes in cerebral blood flow. Changes in the cognitive function scale assessment (memory, executive function, and other five cognitive domains) and brain magnetic resonance imaging examinations are planned to collect both at baseline and after a one-year follow-up. Then the investigator used the multiple linear regression method to analyze the effects of the difference in middle cerebral artery flow on the changes in cognitive function and the characteristics in brain imaging. The investigators anticipate that the characteristics of the influence of changes in cerebral blood flow on cognitive impairment in Chinese MHD patients will be elucidated in this study, which may provide crucial clinical evidence for finding preventive and intervention measures for cognitive impairment in this group of population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
September 17, 2022
CompletedFirst Posted
Study publicly available on registry
September 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedSeptember 27, 2022
September 1, 2022
2.7 years
September 17, 2022
September 22, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in cognitive function which is measured by MoCA scores changes after 1 year follow-up
This study is going to apply neuropsychological battery tests in MoCA assessment and evaluate the changes of MoCA scores of MHD patients after one year of follow-up.
This measurement is going to be completed within 1 year after the last participant enrolls
Eligibility Criteria
Chinese Maintenace Hemodialysis Patients
You may qualify if:
- Age greater than 50, no gender limitation;
- End-stage renal disease, stable dialysis for 3-6 months;
- Subjects voluntarily participated in the study and signed informed consent, and were able to participate in clinical data collection, neuropsychological assessment, transcranial Doppler ultrasound (TCD), head MRI, and 1-year follow-up.
You may not qualify if:
- Congenital mental retardation or disturbance of consciousness, schizophrenia, or history of severe anxiety and depression (Hamilton Depression Scale score more than 17;
- Long-term alcohol or psychotropic drug dependence;
- Those who cannot complete the neuropsychological assessment due to visual impairment, hearing impairment, or limb dysfunction; less than 10 hours of dialysis per week;
- Patients with poor detection of the bilateral temporal window by TCD examination and unable to cooperate with ultrasound examination;
- Those who cannot undergo head MRI examination for various reasons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Shijitan Hospital affiliated to Capital Medical University
Beijing, 100038, China
Study Officials
- PRINCIPAL INVESTIGATOR
Yang Luo, MD, PhD
Beijing Shijitan Hospital Affiliated to Capital Medical University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of nephrology Affiliation
Study Record Dates
First Submitted
September 17, 2022
First Posted
September 27, 2022
Study Start
January 1, 2022
Primary Completion
September 30, 2024
Study Completion
December 31, 2024
Last Updated
September 27, 2022
Record last verified: 2022-09